Patients on GLP-1 or GLP-1/GIP agonists had significant residual gastric volume if the medication was not held prior to upper endoscopy, unless they were on a clear liquid diet the previous day, ...

A 24-year-old man presented for a scheduled elective open reduction and internal fixation of his fractured right fibula. His BMI was 22. During the pre-operative assessment, the patient noted that he ...

The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may lead to an increased risk for aspiration pneumonia after endoscopic procedures, according to a new large population-based study. In ...

Patients on weekly glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have high residual gastric content, a major risk factor for aspiration under anesthesia, despite following fasting guidelines ...

Continued use of a glucagon-like peptide 1 (GLP-1) receptor agonist leading up to surgery may not increase the risk for regurgitation and pulmonary aspiration during operations after all, an analysis ...

European medical officials advised patients taking GLP-1 weight loss and diabetes drugs who will be sedated for an upcoming surgery to warn their doctors about their medication use to avoid the risk ...

Please provide your email address to receive an email when new articles are posted on . Glucagon-like peptide-1 receptor agonists were associated with a higher risk for aspiration pneumonia after ...

Evidence of a role for oropharyngeal cancer cells with low HPV gene expression in treatment failure. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...

Share on Pinterest A new study finds GLP-1 drugs may increase risk of surgical complications. PixelCatchers/Getty Images Obesity and diabetes drugs like Ozempic and Mounjaro could lead to ...